Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site
- PMID: 27172319
- DOI: 10.1021/acs.jmedchem.6b00071
Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site
Abstract
By targeting a new binding region at the interface between αβ-tubulin heterodimers at the colchicine binding site, we designed a series of 7-substituted 1-methyl-1,4-dihydroindeno[1,2-c]pyrazoles as potential tubulin polymerization inhibitors. Among the compounds synthesized, 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-7-yloxy)acetamide 6a and 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-7-yloxy)-N-hydroxyacetamide 6n showed noteworthy low nanomolar potency against HepG2, Hela, PC3, and MCF-7 cancer cell lines. In mechanism studies, 6a inhibited tubulin polymerization and disorganized microtubule in A549 cells by binding to tubulin colchicine binding site. 6a arrested A549 cells in G2/M phase that was related to the alterations in the expression of cyclin B1 and p-cdc2. 6a induced A549 cells apoptosis through the activation of caspase-3 and PARP. In addition, 6a inhibited capillary tube formation in a concentration-dependent manner. In nonsmall cell lung cancer xenografts mouse model, 6a suppressed tumor growth by 59.1% at a dose of 50 mg/kg (ip) without obvious toxicity, indicating its in vivo potential as anticancer agent.
Similar articles
-
Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.Eur J Med Chem. 2018 Aug 5;156:162-179. doi: 10.1016/j.ejmech.2018.05.010. Epub 2018 May 10. Eur J Med Chem. 2018. PMID: 30006162
-
The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.Eur J Med Chem. 2020 Feb 1;187:111968. doi: 10.1016/j.ejmech.2019.111968. Epub 2019 Dec 14. Eur J Med Chem. 2020. PMID: 31865012
-
Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.Eur J Med Chem. 2020 Sep 15;202:112519. doi: 10.1016/j.ejmech.2020.112519. Epub 2020 Jun 27. Eur J Med Chem. 2020. PMID: 32650183
-
Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents.Curr Top Med Chem. 2019;19(15):1289-1304. doi: 10.2174/1568026619666190618130008. Curr Top Med Chem. 2019. PMID: 31210108 Review.
-
Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site.Molecules. 2016 Oct 15;21(10):1375. doi: 10.3390/molecules21101375. Molecules. 2016. PMID: 27754459 Free PMC article. Review.
Cited by
-
A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy.Molecules. 2022 Jan 13;27(2):485. doi: 10.3390/molecules27020485. Molecules. 2022. PMID: 35056800 Free PMC article.
-
Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties.Invest New Drugs. 2020 Feb;38(1):29-38. doi: 10.1007/s10637-019-00753-z. Epub 2019 Mar 18. Invest New Drugs. 2020. PMID: 30887253
-
Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents: Synthesis, Screening, Antiproliferative and Tubulin Polymerization Inhibition Activity.Curr Cancer Drug Targets. 2023;23(4):278-292. doi: 10.2174/1568009623666221028121906. Curr Cancer Drug Targets. 2023. PMID: 36306454
-
Copper-Catalyzed Syntheses of Pyrene-Pyrazole Pharmacophores and Structure Activity Studies for Tubulin Polymerization.ACS Omega. 2018 Jun 30;3(6):6378-6387. doi: 10.1021/acsomega.8b00320. Epub 2018 Jun 13. ACS Omega. 2018. PMID: 30221233 Free PMC article.
-
Synthesis and Selective Anticancer Activity Evaluation of 2-phenylacrylonitrile Derivatives as Tubulin Inhibitors.Curr Med Chem. 2024;31(15):2090-2106. doi: 10.2174/0109298673263854231009063053. Curr Med Chem. 2024. PMID: 38384112 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials
Miscellaneous
